Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Firvanq Generic Name & Formulations
Legal Class
Rx
General Description
Vancomycin HCl 3.75g, 7.5g, 15g; pwd for oral soln after reconstitution; grape-flavored.
Pharmacological Class
Antibiotic.
How Supplied
Kit—1 (w. diluent)
Manufacturer
Generic Availability
NO
Firvanq Indications
Indications
C. difficile-associated diarrhea. Enterocolitis due to S. aureus.
Limitations of Use
Oral vancomycin HCl not effective for treatment of other types of infections.
Firvanq Dosage and Administration
Adult
C. difficile-associated diarrhea: 125mg 4 times a day for 10 days. Enterocolitis: 500mg–2g per day in 3–4 divided doses for 7–10 days.
Children
40mg/kg per day in 3–4 divided doses for 7–10 days; max 2g/day.
Firvanq Contraindications
Not Applicable
Firvanq Boxed Warnings
Not Applicable
Firvanq Warnings/Precautions
Warnings/Precautions
Renal insufficiency and/or colitis. Inflammatory bowel disorders. Underlying hearing loss. Monitor hearing, blood, renal function. Consider monitoring vancomycin serum concentrations. Discontinue at the 1st sign of skin rashes, mucosal lesions, blisters. Not for endophthalmitis prophylaxis. Elderly. Pregnancy. Nursing mothers.
Firvanq Pharmacokinetics
See Literature
Firvanq Interactions
Interactions
Monitor with aminoglycosides, other neurotoxic, nephrotoxic, or ototoxic drugs.
Firvanq Adverse Reactions
Adverse Reactions
Nausea, abdominal pain, hypokalemia; ototoxicity, nephrotoxicity, superinfection, severe dermatologic reactions (eg, TEN, SJS, DRESS, AGEP, LABD).
Firvanq Clinical Trials
See Literature
Firvanq Note
Not Applicable
Firvanq Patient Counseling
See Literature
Images
